Please login to the form below

Not currently logged in
Email:
Password:

Lindsay Rocco to lead corporate communications at Dendreon

Joins from agency Rx Mosaic Health

Lindsay Rocco, DendreonDendreon has appointed Rx Mosaic Health's Lindsay Rocco to executive VP, corporate communications.

The US biotech, which markets prostate cancer vaccine Provenge (sipuleucel-T), said Rocco will be responsible for all communications functions of the company, reporting directly to chair, president and CEO John Johnson.

Rocco was most recently senior VP at healthcare communications agency Rx Mosaic Health, a position she held since February 2010.

She has previous communications experience within the industry too, serving as director, public affairs at Roche, prior to her time at Rx Mosaic Health.

“Lindsay is a seasoned communicator with a deep understanding of the oncology space and a true passion for Dendreon's mission to help advanced prostate cancer patients lead longer and better lives,” said Johnson.

“Lindsay's energy and expertise in healthcare communications makes her an ideal addition to our leadership team.”

15th November 2012

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics